Skip to main content

Table 7 Comparison of features between IBDU, CD-reclassified and UC-reclassified groups [cases (%)]

From: Clinical features of inflammatory bowel disease unclassified: a case-control study

 

IBDU (20)

UC- reclassified (9)

p-value

CD- reclassified (8)

p-value

albuminemia (g/L), mean ± sd

35.0 ± 6.2

30.4 ± 6.5

0.049

33.0 ± 6.9

0.386

mucopurulent bloody stool, n (%)

12(60.0%)

8(88.9%)

0.201

4(50.0%)

0.691

hemorrhage, n (%)

3(15.0%)

4(44.4%)

0.158

5(62.5%)

0.022

perforation, n (%)

1(5.0%)

2(22.2%)

0.220

2(25.0%)

0.188

perianal disease, n (%)

4(20.0%)

2(22.2%)

1.000

5(62.5%)

0.068

fistula, n (%)

4(20.0%)

1(11.1%)

0.654

4(50.0%)

0.172

obstruction, n (%)

6(30.0%)

1(11.1%)

0.382

5(62.5%)

0.200

rectal involvement, n (%)

7(35.0%)

5(55.6%)

0.422

3(37.5%)

1.000

stricture, n (%)

13(65.0%)

7(77.8%)

0.675

7(87.5%)

0.371

segmental lesion, n (%)

15(75.0%)

6(66.7%)

0.483

5(62.5%)

0.651

longitudinal ulcer, n (%)

8(40.0%)

2(22.2%)

0.431

5(62.5%)

0.410

crypt abscess, n (%)

11(55.0%)

5(55.6%)

1.000

5(62.5%)

1.000

granuloma, n (%)

1(5.0%)

0(0.0%)

1.000

1(12.5%)

0.497

Surgery, n (%)

6(30.0%)

3(33.3%)

1.000

6(75.0%)

0.044

Corticosteroid, n (%)

19(95.0%)

9(100.0%)

1.000

8(100.0%)

1.000

IM, n (%)

9(45.0%)

7(77.8%)

0.130

7(87.5%)

0.088

IFX, n (%)

4(20.0%)

1(11.1%)

1.000

4(50.0%)

0.172